Short: To encourage innovative health services research that can directly and demonstrably contribute to the improvement of minority health and/or the reduction of health disparities at the health care system-level as well as within clinical settings.
Long: The overarching purpose of this FOA is to promote research to generate new knowledge to improve health care access, delivery, utilization and quality, and health outcomes of racial and ethnic minority populations and other groups affected by health disparities. Research encouraged under this FOA includes the examination of population-specific clinical presentation and/or manifestation of diseases and their complications within the context of health care settings; services within health care systems and non-clinical settings linked to health care systems (e.g. personal residences, school-based health centers, the workplace, and criminal justice settings); etiologies and reduction of health care disparities; structure and organization of health care systems and coordination of health care; impact of healthcare and non-healthcare policies on health care and health disparities; and system-wide interventions or multi-level interventions. Projects may address health services pertaining to health promotion, screening for disease or risk factors, prevention at any level, diagnosis and the treatment of particular health conditions (including chronic diseases, mental and substance abuse disorders, and infectious diseases such the 2019 Novel Coronavirus), specific segments of populations affected by health disparities (e.g. pregnant women, children, persons with disabilities, older adults), or more general indicators (e.g., access to primary care services or specialty care) that may not be condition-specific. Projects may include observational/descriptive, or interventional studies (including randomized clinical trials, pragmatic trials and others) and may involve primary data collection and/or secondary analysis of existing datasets. Projects should involve the use of relevant health system-level data in some way. Projects should include a focus on one or more NIH-designated US populations affected by health disparities, which include Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asian Americans, Native Hawaiians and other Pacific Islanders, socioeconomically disadvantaged populations, underserved rural populations, and sexual and gender minorities. Projects that include populations that identify across more than one health disparity group are encouraged.
Eligibility
Eligible Organizations: Higher Education Institutions, Nonprofits Other Than Institutions of Higher Education, For-Profit Organizations, Local Governments, Federal Governments, and Other
Eligible Individuals (Program Director/Principal Investigator): Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
Level of funding provided
Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Deadlines
November 27, 2020; March 17, 2021; November 17, 2021; March 17, 2022; November 17 2022; February 17, 2023.
Vernita Gordon, Ph.D., of the University of Texas at Austin
“Assessing the roles of biofilm structure and mechanics in pathogenic, persistent infections” (Forms-D)
Monica Gandhi, M.D., of the University of California, San Francisco
“Hair Extensions: Using Hair Levels to Interpret Adherence, Effectiveness and Pharmacokinetics with Real-World Oral PrEP, the Vaginal Ring, and Injectables” (Forms-D)
Tom Muir, Ph.D., of Princeton University
“Peptide Autoinducers of Staphylococcal Pathogenicity” (Forms-D)
For detailed information on examples: https://www.niaid.nih.gov/grants-contracts/sample-applications